David Juurlink

David Juurlink (/ˈjʊərlɪŋk/ YURE-link;^[2] born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research.^[3] He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol^[4] and fentanyl.^[5][6] In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.^[7]

David Juurlink
Born	1968 (age 56–57) New Glasgow, Nova Scotia, Canada
Alma mater	Dalhousie University[1]
Occupation	Physician